Erin F. Barreto, Pharm.D., Ph.D., R.Ph., BCCCP

Closed for Enrollment

• AKI in Care Transitions (ACT) Trial (AKI ACT) Rochester, Minn.

  The purpose of this study is to evaluate the feasibility and acceptability of the AKI in Care Transitions pilot and iteratively refine the intervention.  Generate preliminary estimates of the ACT intervention on clinical and patient-reported outcomes.

• Enhanced Kidney Follow-up for AKI Survivors in Care Transitions (The ACT Study): Impact on Patient Reported Outcomes (ACT Study) Rochester, Minn.

  The purpose of this study is to assess the ability of education and outpatient kidney care follow-up to improve patient knowledge about acute kidney injury (AKI).

   

   

   

• Pharmacokinetic Evaluation of Antipseudomonal Beta-lactams in Critically Ill Patients (Prospective BLOOM) Rochester, Minn.

  The purpose of this study is to observe and characterize the pharmacokinetics of anti-pseudomonal beta-lactam antibiotics (cefepime, piperacillin/tazobactam, meropenem) in critically ill adults..